An Rb-Skp2-p27 pathway mediates acute cell cycle inhibition by Rb and is retained in a partial-penetrance Rb mutant.

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Molecules and Cells

• Publication date

  2004-10-08

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/J.MOLCEL.2004.09.029PMID 15469821
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Degradation of the SCF component Skp2 in cell-cycle phase G1 by the anaphase-promoting complex

  2004influential reference
• Control of the SCFSkp2–Cks1 ubiquitin ligase by the APC/CCdh1 ubiquitin ligase

  2004cited by this paper
• Skp2-mediated degradation of p27 regulates progression into mitosis.

  2004cited by this paper
• Control of the SCF(Skp2-Cks1) ubiquitin ligase by the APC/C(Cdh1) ubiquitin ligase.

  2004cited by this paper
• The Retinoblastoma Protein and Cell Cycle Control Review

  2004cited by this paper
• Multisite phosphorylation by Cdk2 and GSK3 controls cyclin E degradation.

  2003cited by this paper
• Proliferation of cancer cells despite CDK2 inhibition.

  2003cited by this paper
• Ratchets and clocks: the cell cycle, ubiquitylation and protein turnover

  2003cited by this paper
• Deregulated degradation of the cdk inhibitor p27 and malignant transformation.

  2003cited by this paper
• Expression of the F-box protein SKP2 induces hyperplasia, dysplasia, and low-grade carcinoma in the mouse prostate.

  2003cited by this paper
• Efficient Gene Delivery and Targeted Expression to Hepatocytes In Vivo by Improved Lentiviral Vectors

  2002cited by this paper
• Suppression of the p53- or pRB-mediated G1 checkpoint is required for E2F-induced S-phase entry

  2002cited by this paper
• The pRb-related protein p130 is regulated by phosphorylation-dependent proteolysis via the protein-ubiquitin ligase SCF(Skp2).

  2002cited by this paper
• Skp2 is oncogenic and overexpressed in human cancers

  2001cited by this paper
• Role of the F-Box Protein Skp2 in Adhesion-Dependent Cell Cycle Progression

  2001cited by this paper
• Role of the F-box protein Skp2 in lymphomagenesis

  2001cited by this paper
• PTEN regulates the ubiquitin-dependent degradation of the CDK inhibitor p27(KIP1) through the ubiquitin E3 ligase SCF(SKP2).

  2001cited by this paper
• A mouse knock-in model exposes sequential proteolytic pathways that regulate p27Kip1 in G1 and S phase

  2001cited by this paper
• Requirement for p27KIP1 in Retinoblastoma Protein-Mediated Senescence

  2001cited by this paper
• Targeted disruption of Skp2 results in accumulation of cyclin E and p27Kip1, polyploidy and centrosome overduplication

  2000cited by this paper
• The Rb/E2F pathway: expanding roles and emerging paradigms.

  2000cited by this paper
• pRB and p107 have distinct effects when expressed in pRB-deficient tumor cells at physiologically relevant levels

  2000cited by this paper
• p27(Kip1) ubiquitination and degradation is regulated by the SCF(Skp2) complex through phosphorylated Thr187 in p27.

  1999cited by this paper
• A new pathway for mitogen-dependent cdk2 regulation uncovered in p27(Kip1)-deficient cells.

  1999cited by this paper
• p45SKP2 promotes p27Kip1 degradation and induces S phase in quiescent cells

  1999cited by this paper
• p27 and Rb are on overlapping pathways suppressing tumorigenesis in mice.

  1999cited by this paper
• Identification of a family of human F-box proteins.

  1999cited by this paper
• SKP2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27

  1999cited by this paper
• The murine gene p27Kip1 is haplo-insufficient for tumour suppression

  1998cited by this paper
• Stable binding to E2F is not required for the retinoblastoma protein to activate transcription, promote differentiation, and suppress tumor cell growth.

  1998cited by this paper
• Requirement of Cyclin E-Cdk2 Inhibition in p16INK4a-Mediated Growth Suppression

  1998cited by this paper
• Growth Suppression by an E2F-Binding-Defective Retinoblastoma Protein (RB): Contribution from the RB C Pocket

  1998influential reference
• Regulation of E2F through ubiquitin-proteasome-dependent degradation: stabilization by the pRB tumor suppressor protein.

  1997cited by this paper
• Cell cycle regulation by the ubiquitin pathway

  1997cited by this paper
• Incomplete penetrance of familial retinoblastoma linked to germ-line mutations that result in partial loss of RB function.

  1997influential reference
• Altered cell cycle kinetics, gene expression, and G1 restriction point regulation in Rb-deficient fibroblasts

  1996cited by this paper
• Turnover of cyclin E by the ubiquitin-proteasome pathway is regulated by cdk2 binding and cyclin phosphorylation.

  1996cited by this paper
• Degradation of E2F by the ubiquitin-proteasome pathway: regulation by retinoblastoma family proteins and adenovirus transforming proteins.

  1996cited by this paper
• Activation of cyclin E/CDK2 is coupled to site‐specific autophosphorylation and ubiquitin‐dependent degradation of cyclin E.

  1996cited by this paper
• The retinoblastoma gene product protects E2F-1 from degradation by the ubiquitin-proteasome pathway.

  1996cited by this paper
• The retinoblastoma protein and cell cycle control.

  1995cited by this paper
• p27Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-beta and contact inhibition to cell cycle arrest.

  1994cited by this paper

• Activation of Smo/Gli1 pathway attenuates cardiac fibrosis by suppressing G1 / S phase transition and cell proliferation in cardiac fibroblasts in mice.

  2025cites this paper
• Estradiol Downregulates MicroRNA-193a to Mediate Its Anti-Mitogenic Actions on Human Coronary Artery Smooth Muscle Cell Growth

  2025cites this paper
• Targeting the Skp2-Cks1 protein-protein interaction: structures, assays, and preclinical inhibitors.

  2025cites this paper
• Distinct outcomes from targeted perturbations of the multi-subunit SCFSkp2 E3 ubiquitin ligase in blocking Trp53/Rb1-null prostate tumorigenesis

  2025cites this paper
• Recent progress in Retinoblastoma: Pathogenesis, Presentation, Diagnosis and Management.

  2024cites this paper
• Novel insights into RB1 in prostate cancer lineage plasticity and drug resistance

  2024cites this paper
• Molecular mechanisms underlying the regulation of tumour suppressor genes in lung cancer.

  2024cites this paper
• Therapeutic effect of novel drug candidate, PRG-N-01, on NF2 syndrome-related tumor

  2024cites this paper
• LKB1 dictates sensitivity to immunotherapy through Skp2-mediated ubiquitination of PD-L1 protein in non-small cell lung cancer

  2024cites this paper
• Therapeutic Strategies for RB1-Deficient Cancers: Intersecting Gene Regulation and Targeted Therapy

  2024cites this paper
• Targeted pharmacologic inhibition of S-phase kinase-associated protein 2 (SKP2) mediated cell cycle regulation in lung and other RB-Related cancers: A brief review of current status and future prospects.

  2023cites this paper
• Retinoblastoma Protein Is Required for Epstein-Barr Virus Replication in Differentiated Epithelia

  2023cites this paper
• Punicalagin alleviates the hyperproliferation of keratinocytes in psoriasis through inhibiting SKP2 expression

  2023cites this paper
• Bromocriptine monotherapy overcomes prostate cancer chemoresistance in preclinical models

  2023cites this paper
• Targeted inhibition of SCFSKP2 confers anti-tumor activities resulting in a survival benefit in osteosarcoma

  2023cites this paper
• Cell cycle exits and U-turns: Quiescence as multiple reversible forms of arrest

  2023cites this paper
• Targeting the untargetable: RB1-deficient tumours are vulnerable to Skp2 ubiquitin ligase inhibition

  2022cites this paper
• Bacterial protein MakA causes suppression of tumour cell proliferation via inhibition of PIP5K1α/Akt signalling

  2022cites this paper
• Molecular Mechanisms of MmuPV1 E6 and E7 and Implications for Human Disease

  2022cites this paper
• Novel insights into RB1 mutation.

  2022cites this paper
• Emerging New Therapeutics for Retinoblastoma

  2022cites this paper
• Cell cycle regulation: p53-p21-RB signaling

  2022cites this paper
• Understanding Retinoblastoma Post-Translational Regulation for the Design of Targeted Cancer Therapies

  2022cites this paper
• Synergistic Silencing of Skp2 by siRNA Self-Assembled Nanoparticles as a Therapeutic Strategy for Advanced Prostate Cancer.

  2022cites this paper
• Genetics of Retinoblastoma

  2022cites this paper
• Anticancer Effects and Molecular Action of 7-α-Hydroxyfrullanolide in G2/M-Phase Arrest and Apoptosis in Triple Negative Breast Cancer Cells

  2022cites this paper
• Targeting RB1 Loss in Cancers

  2021cites this paper
• Pro-Apoptotic Potential of Pseudevernia furfuracea (L.) Zopf Extract and Isolated Physodic Acid in Acute Lymphoblastic Leukemia Model In Vitro

  2021cites this paper
• The Mus musculus Papillomavirus Type 1 E7 Protein Binds to the Retinoblastoma Tumor Suppressor: Implications for Viral Pathogenesis

  2021cites this paper
• The interaction of SKP2 with p27 enhances the progression and stemness of osteosarcoma

  2021cites this paper
• Bipartite binding of the N terminus of Skp2 to cyclin A.

  2021cites this paper
• The Mus musculus papillomavirus type 1 E7 protein binds to the retinoblastoma tumor suppressor - implications for viral pathogenesis

  2021cites this paper
• Targeted Inhibition of the E3 Ligase SCFSkp2/Cks1 Has Antitumor Activity in RB1-Deficient Human and Mouse Small-Cell Lung Cancer

  2020cites this paper
• Integrative analysis of large-scale loss-of-function screens identifies robust cancer-associated genetic interactions

  2020cites this paper
• The Skp2 Pathway: A Critical Target for Cancer Therapy.

  2020cites this paper
• Does the proteasome inhibitor bortezomib sensitize to DNA-damaging therapy in gastroenteropancreatic neuroendocrine neoplasms? – A preclinical assessment in vitro and in vivo

  2020cites this paper
• Discriminative SKP2 Interactions with CDK-Cyclin Complexes Support a Cyclin A-Specific Role in p27KIP1 Degradation

  2020cites this paper
• Retinoblastoma: Etiology, Modeling, and Treatment

  2020cites this paper
• Cancer genomics of lung cancer including malignant mesothelioma: A brief overview of current status and future prospects.

  2020cites this paper
• Skp2 in the ubiquitin-proteasome system: A comprehensive review.

  2020cites this paper
• Characterization of human‐induced pluripotent stem cells carrying homozygous RB1 gene deletion

  2020cites this paper
• Ubiquitin-Regulated Cell Proliferation and Cancer.

  2020cites this paper
• Time varying causal network reconstruction of a mouse cell cycle

  2019cites this paper
• A Code of Mono-phosphorylation Modulates the Function of RB.

  2019cites this paper
• Robust genetic interactions in cancer are enriched in protein-protein interaction pairs

  2019cites this paper
• DREAM and RB cooperate to induce gene repression and cell-cycle arrest in response to p53 activation

  2019cites this paper
• Natural (and Unnatural) Small Molecules as Pharmacological Chaperones and Inhibitors in Cancer.

  2018cites this paper
• Context dependent roles for RB-E2F transcriptional regulation in tumor suppression

  2018cites this paper
• Targeting Trafficking in Drug Development

  2018cites this paper
• Dysregulated expression of SKP2 and its role in hematological malignancies

  2018cites this paper
• Expression of HER2-neu, SKP2, and hypoxia-inducible factor-1 and their role in predicting the response of muscle-invasive urothelial carcinoma to bladder preservation chemotherapy

  2018cites this paper
• E2F1 inhibition mediates cell death of metastatic melanoma

  2018cites this paper
• Multiple functions of p27 in cell cycle, apoptosis, epigenetic modification and transcriptional regulation for the control of cell growth: A double-edged sword protein.

  2018cites this paper
• Identification of highly penetrant Rb-related synthetic lethal interactions in triple negative breast cancer

  2018cites this paper
• Cell-Cycle Therapeutics Come of Age.

  2017cites this paper
• Intersection of retinoblastoma tumor suppressor function, stem cells, metabolism, and inflammation

  2017cites this paper
• MiR-661 promotes tumor invasion and metastasis by directly inhibiting RB1 in non small cell lung cancer

  2017cites this paper
• MYC Modulation around the CDK2/p27/SKP2 Axis

  2017cites this paper
• Multiple molecular interactions redundantly contribute to RB-mediated cell cycle control

  2017cites this paper
• Cellular Homeostasis and Antioxidant Response in Epithelial HT29 Cells on Titania Nanotube Arrays Surface

  2017cites this paper
• p27T187A knockin identifies Skp2/Cks1 pocket inhibitors for advanced prostate cancer

  2017cites this paper
• Intersection of retinoblastoma tumor suppressor function, stem cells, metabolism, and inflammation

  2017cites this paper
• Ubiquitin in Cell-Cycle Regulation and Dysregulation in Cancer

  2017cites this paper
• Investigating E2F independent cell cycle control and tumor suppression by pRB

  2017cites this paper
• Cell death, cell growth and cell cycle regulation by the Retinoblastoma family

  2017influential citation
• Cell cycle transcription control: DREAM/MuvB and RB-E2F complexes

  2017cites this paper
• Genomic instability and proliferation/survival pathways in RB1-deficient malignancies.

  2017cites this paper
• Deletions of Retinoblastoma 1 (Rb1) and Its Repressing Target S Phase Kinase-associated protein 2 (Skp2) Are Synthetic Lethal in Mouse Embryogenesis*

  2016cites this paper
• APC/C and retinoblastoma interaction: cross-talk of retinoblastoma protein with the ubiquitin proteasome pathway

  2016cites this paper
• TIMELESS Suppresses the Accumulation of Aberrant CDC45·MCM2-7·GINS Replicative Helicase Complexes on Human Chromatin*

  2016cites this paper
• Logical model specification aided by model-checking techniques: application to the mammalian cell cycle regulation

  2016cites this paper
• Interchangeable Roles for E2F Transcriptional Repression by the Retinoblastoma Protein and p27KIP1–Cyclin-Dependent Kinase Regulation in Cell Cycle Control and Tumor Suppression

  2016influential citation
• Model Building by Temporal Logic Constraint Solving : Investigation of the Coupling between the Cell Cycle and the Circadian Clock

  2016cites this paper
• RB1: a prototype tumor suppressor and an enigma

  2016cites this paper
• Drugging the addict: non‐oncogene addiction as a target for cancer therapy

  2016cites this paper
• DEPARTMENT OF DEVELOPMENTAL AND MOLECULAR BIOLOGY

  2016cites this paper
• Retinoblastoma tumor suppressor functions shared by stem cell and cancer cell strategies.

  2016cites this paper
• Regulation of the retinoblastoma-E2F pathway by the ubiquitin-proteasome system.

  2015cites this paper
• The Evolutionarily Conserved C-terminal Domains in the Mammalian Retinoblastoma Tumor Suppressor Family Serve as Dual Regulators of Protein Stability and Transcriptional Potency*

  2015cites this paper
• Flavokawain A induces deNEDDylation and Skp2 degradation leading to inhibition of tumorigenesis and cancer progression in the TRAMP transgenic mouse model

  2015cites this paper
• Proteomic analysis of pRb loss highlights a signature of decreased mitochondrial oxidative phosphorylation

  2015cites this paper
• pRb-E2F signaling in life of mesenchymal stem cells: Cell cycle, cell fate, and cell differentiation

  2014cites this paper
• Antitumor mechanisms when pRb and p53 are genetically inactivated

  2014cites this paper
• Signaling through cyclin D-dependent kinases

  2014cites this paper
• Der Einfluss von advanced glycation end-products auf die podozytäre Expression des nuklearen Inhibitors der Proteinphosphatase 1

  2014cites this paper
• Logical modeling of the cell cycle

  2014cites this paper
• AWARD NUMBER: W81XWH-13-1-0409 TITLE: The Role of Skp2 in the Prostate Tumorigenesis Following Rb and p53 Loss PRINCIPAL INVESTIGATOR:

  2014cites this paper
• Coordination of proliferation and neuronal differentiation by the retinoblastoma protein family

  2014cites this paper
• Skp2 suppresses apoptosis in Rb1 deficient tumors by limiting E2F1 activity

  2014cites this paper
• SCFs in the new millennium

  2014cites this paper
• Mcl1 regulates the terminal mitosis of neural precursor cells in the mammalian brain through p27Kip1

  2013cites this paper
• Molecular mechanisms underlying RB protein function

  2013cites this paper
• RETINOBLASTOMA-RELATED Protein Stimulates Cell Differentiation in the Arabidopsis Root Meristem by Interacting with Cytokinin Signaling[W]

  2013cites this paper
• Deciphering the retinoblastoma protein phosphorylation code.

  2013cites this paper
• Established and new mouse models reveal E2f1 and Cdk2 dependency of retinoblastoma, and expose effective strategies to block tumor initiation

  2013cites this paper
• To Grow, Stop or Die? – Novel Tumor-Suppressive Mechanism Regulated by the Transcription Factor E2F

  2013cites this paper
• Chapter 2 To Grow , Stop or Die ? – Novel Tumor-Suppressive Mechanism Regulated by the Transcription Factor E 2 F

  2013cites this paper
• Understanding pRb: toward the necessary development of targeted treatments for retinoblastoma.

  2012cites this paper
• Senescence is an endogenous trigger for microRNA-directed transcriptional gene silencing in human cells

  2012cites this paper
• Clinicopathologic significance and function of S-phase kinase-associated protein 2 overexpression in hepatocellular carcinoma.

  2012cites this paper